Science Explorer Back to mapMap
Discussion
Institution · Bleeding & Clotting Disorders Institute

Most cited papers from Bleeding & Clotting Disorders Institute

Bleeding & Clotting Disorders Institute

What are the most cited papers from Bleeding & Clotting Disorders Institute?

The most cited paper from Bleeding & Clotting Disorders Institute is "International consensus report on the investigation and management of primary immune thrombocytopenia" (Drew Provan et al., 2009), with 2,283 citations. Next come "Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial" (872) and "Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination" (392).

Showing 50 of 60 papers. Every paper with more than 16 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan et al. · Blood Open access 21 Oct 2009 2,283
2 Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter et al. · The Lancet Feb 2008 872
3 Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination Eun‐Ju Lee, Douglas B. Cines, Terry Gernsheimer et al. · American Journal of Hematology Open access 19 Feb 2021 392
4 Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study Michael D. Tarantino, James Bruce Bussel, Victor S. Blanchette et al. · The Lancet 22 Apr 2016 158
5 Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin‐free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A1 Michael D. Tarantino, Peter W. Collins, C. R. M. Hay et al. · Haemophilia Sep 2004 140
6 Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia Patrick F Fogarty, Michael D. Tarantino, Andrés Brainsky et al. · Current Medical Research and Opinion 28 Nov 2011 114
7 Single dose of anti-D immune globulin at 75μg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children Michael D. Tarantino, Guy A. Young, Salvatore J. Bertolone et al. · The Journal of Pediatrics Apr 2006 112
8 Value of Isolated IgA Anti–β2‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome Vijaya L. Murthy et al. · Arthritis & Rheumatism Open access 27 Aug 2013 110
9 Consensus recommendations for use of central venous access devices in haemophilia Bruce M. Ewenstein, Leonard A. Valentino, J. M. Journeycake et al. · Haemophilia Sep 2004 104
10 Factor VIII replacement is still the standard of care in haemophilia A. Louis M. Aledort, Pier Mannuccio Mannucci, Wolfgang Schramm et al. · PubMed Open access Nov 2019 101
11 Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia Paul Edward Monahan, Claude Négrier, Michael D. Tarantino et al. · Journal of Clinical Medicine Open access 2 Jun 2021 87
12 An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois Amar Harry Kelkar, Nichole A. Smith, Annia Martial et al. · New England Journal of Medicine 26 Sep 2018 87
13 Pilot dose‐finding and safety study of bivalirudin in infants <6 months of age with thrombosis Guy A. Young, Michael D. Tarantino, Julie D. Wohrley et al. · Journal of Thrombosis and Haemostasis Open access 23 Jul 2007 79
14 SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP Eun‐Ju Lee, Marina Beltrami Moreira, Hanny T. Al-Samkari et al. · Blood Open access 29 Sep 2021 72
15 Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia Ralph Vincent Boccia, Nichola Cooper, Waleed Ghanima et al. · British Journal of Haematology Open access 23 Jul 2020 72
16 Recombinant porcine sequence factor VIII (rp FVIII ) for acquired haemophilia A: practical clinical experience of its use in seven patients Michael D. Tarantino, Adam C. Cuker, Brandon M. Hardesty et al. · Haemophilia Open access 10 Aug 2016 68
17 Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine Jackie M. Helms, Kristin T Ansteatt, Jonathan C. Roberts et al. · Journal of Blood Medicine Open access Apr 2021 67
18 Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis Derek A. Weycker, Ahuva Hanau, Mark D. Hatfield et al. · Journal of Medical Economics Open access 24 Sep 2019 66
19 Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients Amy Shapiro, Erik E. Berntorp, Ingrid Pabinger et al. · Thrombosis and Haemostasis 2008 66
20 RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME) Jenny McDade Despotovic, Michele P. Lambert, Jay Howard Herman et al. · Transfusion Open access 7 Oct 2011 65
21 Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study Guy A. Young, Marilyn J. Manco‐Johnson, Joan Cox Gill et al. · Journal of Thrombosis and Haemostasis Open access May 2003 59
22 Laboratory diagnosis of v on W illebrand disease Jonathan C. Roberts, Veronica Heather Flood · International Journal of Laboratory Hematology Open access May 2015 59
23 Comparative pharmacokinetics of rVIII ‐SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A Robert Klamroth, Mindy L. Simpson, M. von Depka‐Prondzinski et al. · Haemophilia Open access 19 Jul 2016 57
24 The incidence and outcome of intracranial haemorrhage in newborns with haemophilia: analysis of the Nationwide Inpatient Sample database Michael D. Tarantino, Shivani Gupta, R. M. BRUSKY · Haemophilia 22 May 2007 57
25 Surveillance of infectious complications associated with central venous access devices in children with haemophilia Michael D. Tarantino, Alice E. Lail, Sharyne M Donfield et al. · Haemophilia Sep 2003 50
26 Bivalirudin for anticoagulation in children Sobharani Rayapudi, Adalberto Torres, Girish G. Deshpande et al. · Pediatric Blood & Cancer 25 Sep 2008 48
27 An update on the new classification of Ehlers‐Danlos syndrome and review of the causes of bleeding in this population Rohith Jesudas, Ateefa Chaudhury, Christina M. Laukaitis · Haemophilia 10 Jun 2019 44
28 Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept J.R. McMinn, Steven M. Cohen, Joseph O. Moore et al. · American Journal of Hematology Open access 9 May 2003 43
29 Goal Attainment Scaling for haemophilia ( GAS ‐Hēm): testing the feasibility of a new patient‐centric outcome measure in people with haemophilia Jonathan C. Roberts, Susan Lattimore, Michael Recht et al. · Haemophilia Open access 6 Apr 2018 41
30 The GOAL‐Hēm journey: Shared decision making and patient‐centred outcomes Jonathan C. Roberts, Sharon Richardson, Moses E. Miles et al. · Haemophilia Open access 21 Jun 2022 39
31 Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura Ellen L. Pratt, Michael D. Tarantino, Debra Wagner et al. · American Journal of Hematology 24 Jun 2005 38
32 Characterization of the anti‐factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence‐based immunoassay Brian Boylan et al. · Journal of Thrombosis and Haemostasis Open access 29 Oct 2014 37
33 Diagnosis and treatment of von Willebrand disease Joan Cox Gill · Hematology/Oncology Clinics of North America Dec 2004 35
34 Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study David J. Kuter, James Bruce Bussel, Waleed Ghanima et al. · Therapeutic Advances in Hematology Open access 2023 34
35 Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia Michael D. Tarantino, James Bruce Bussel, Victor S. Blanchette et al. · Haematologica Open access 7 Mar 2019 34
36 Healthcare resource utilization among haemophilia A patients in the United States Leonard A. Valentino, Steven W. Pipe, Michael D. Tarantino et al. · Haemophilia Open access 2 Nov 2011 33
37 Romiplostim as a treatment for immune thrombocytopenia: a review Michael D. Tarantino, Sarah Chalmers · Journal of Blood Medicine Open access 2015 33
38 A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP) Michael D. Tarantino, James Bruce Bussel, Douglas B. Cines et al. · Blood Open access 6 Jun 2007 31
39 The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States Jaime L. Shaw, Karynsa Kilpatrick, Melissa Jeanne Eisen et al. · Platelets 4 Jul 2019 30
40 Risk factors associated with intraventricular hemorrhage in extremely premature neonates Jonathan C. Roberts, Munaza Javed, James Randolph Sanders Hocker et al. · Blood Coagulation & Fibrinolysis 8 Sep 2017 30
41 Consequences of switching from prophylactic treatment to on‐demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study M. J. Manco‐Johnson, Jeffrey S. Sanders, Nadia P. Ewing et al. · Haemophilia 11 Jun 2013 29
42 Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate Maureen K. Baldwin, Homa Khorrami Ahmadzia, Diane L. Bartlett et al. · Expert Review of Hematology Open access 15 Mar 2023 28
43 Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B‐ HERO ‐S) study Tyler W. Buckner, Michelle Witkop, Christine Guelcher et al. · European Journal Of Haematology Open access 20 Mar 2017 28
44 Update on the management of immune thrombocytopenic purpura in children Michael D. Tarantino, Paula H. B. Bolton‐Maggs · Current Opinion in Hematology Aug 2007 28
45 Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity Ann M. Janssens, Michael D. Tarantino, Robert J Bird et al. · Acta Haematologica Open access 2015 28
46 New directions to develop therapies for people with hemophilia Pooja Gogia, Michael D. Tarantino, Wolfgang Schramm et al. · Expert Review of Hematology Open access 8 Mar 2023 24
47 Contralateral Trigeminal Nerve Dysfunction as a False Localizing Sign in Acoustic Neuroma: A Clinical and Electrophysiological Study Matthew Koenig, Krishna Kalyan‐Raman, Om N. Sureka · Neurosurgery Mar 1984 24
48 Depression and anxiety in persons with Von Willebrand disease Jonathan C. Roberts, Roshni Kulkarni, Peter A. Kouides et al. · Haemophilia Open access 14 Dec 2022 23
49 Eculizumab for refractory thrombosis in antiphospholipid syndrome Habiba Hussain, Michael D. Tarantino, Shruti Chaturvedi et al. · Blood Advances Open access 20 Jan 2022 23
50 Hospitalizations in pediatric patients with immune thrombocytopenia in the United States Michael D. Tarantino, Mark D. Danese, Robert J. Klaassen et al. · Platelets Open access 4 Mar 2016 22

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.